Addition of Muramyl Tripeptide to Chemotherapy for Patients with Newly Diagnosed Metastatic Osteosarcoma: a Report from the Children's Oncology Group

BACKGROUND: The addition of liposomal muramyl tripeptide phosphatidylethanolamine (L-MTPPE) to chemotherapy has been shown to improve overall survival in patients with non-metastatic osteosarcoma (OS). We report the results of L-MTP-PE addition to chemotherapy for patients with metastatic OS. METHOD...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Chou, Alexander J., Kleinerman, Eugenie S., Krailo, Mark D., Chen, Zhengjia, Betcher, Donna L., Healey, John H., Conrad, Ernest U., Nieder, Michael L., Weiner, Michael A., Wells, Robert J., Womer, Richard B., Meyers, Paul A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2009
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2783515/
https://ncbi.nlm.nih.gov/pubmed/19637348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24566
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia